Bryan Supran
Fortune : 5 M $ au 31/05/2026
Fortune : 5 M $ au 31/05/2026
Bryan A. Supran is Director at Anacor Pharmaceuticals LLC since 2016.
Mr. Supran is Secretary, Chief Legal Officer & Executive VP at Alnylam Pharmaceuticals, Inc. starting in 2025.
Mr. Supran was Senior Vice President & Deputy General Counsel at Pfizer Inc. from 2016 to 2025.
Mr. Supran was Non-Executive Director at Haleon Plc from 2022 to 2025.
Mr. Supran was Director at Haleon UK Holdings (No.2) Ltd. from 2019 to 2022.
Mr. Supran was Director at Medivation LLC (California).
Mr. Supran was Director at Viatris, Inc. Mr. Supran was Director & Vice President at Array BioPharma, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 14 565 ( 0,01% ) | 4 M $ | 31/05/2026 | |
| 31/12/2025 | 50 000 ( 0% ) | 226 928 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur/Membre du Conseil | 24/06/2016 |
| ALNYLAM PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/09/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Conseiller Juridique Général | - |
| HALEON PLC | Directeur/Membre du Conseil | 25/02/2025 |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 18/07/2022 |
| VIATRIS INC. | Directeur/Membre du Conseil | 16/11/2020 |
| ARRAY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Haleon Plc
Haleon Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures oral, pain relief, digestive and respiratory health products, vitamins & supplements | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national